Sensitivity comparison of longitudinal cognitive function indicators of Alzheimer’s disease after mild cognitive impairment: a prospective cohort study
Authors:
Open Access
- 22 March 2026
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
Accurate prediction of progression from mild cognitive impairment (MCI) to Alzheimer’s disease (AD) is critical for early intervention. Many existing models lack the ability to capture the nonlinear nature of cognitive decline and individual heterogeneity. This study employed a semi‑parametric joint model to analyze longitudinal cognitive trajectories and identify robust predictors of conversion. Data from 596 participants (184 AD converters, 412 stable MCI) were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Longitudinal assessments included ADAS‑Cog13, ADAS‑Cog11, CDR‑SB, FAQ, RAVLT‑IR, RAVLT‑L, and MMSE. A semi‑parametric joint model combining B‑splines for the longitudinal process with a Cox survival submodel was fitted for each cognitive measure. Model performance was evaluated using AIC, BIC, intraclass correlation coefficient (ICC), time‑dependent C‑index, dynamic AUC, and calibration curves. Subgroup analyses were conducted by APOE‑ε4 carrier status. In multivariable joint models, APOE‑ε4 carriage was a consistent risk factor (HR range: 1.38–1.77). Higher scores on ADAS‑Cog13 (HR = 3.71 per SD), ADAS‑Cog11 (HR = 2.71), CDR‑SB (HR = 3.79), and FAQ (HR = 2.85) increased the hazard of conversion, whereas higher scores on RAVLT‑IR (HR = 0.23), RAVLT‑L (HR = 0.14), and MMSE (HR = 0.53) were protective. All models showed high ICCs (0.94–0.98) and moderate‑to‑good predictive accuracy over 2, 5, and 8 year horizons (C‑index: 0.585–0.668). CDR‑SB and FAQ exhibited the strongest effect sizes and clearest dose‑dependent trajectories across APOE‑ε4 subgroups. Calibration curves demonstrated good agreement between predicted and observed survival. The semi‑parametric joint model effectively captures nonlinear cognitive‑functional decline and provides validated predictions of AD risk. APOE‑ε4 genotype combined with longitudinal monitoring of CDR‑SB and FAQ offers a robust framework for stratifying progression risk in clinical MCI management.Keywords
Funding Information
- National Natural Science Foundation of China (81803337)
- National Natural Science Foundation of China (81803337)
- National Natural Science Foundation of China (81803337)
- National Natural Science Foundation of China (81803337)
- National Natural Science Foundation of China (81803337)
- National Natural Science Foundation of China (81803337)
- National Natural Science Foundation of China (81803337)
- National Natural Science Foundation of China (81803337)
- National Natural Science Foundation of China (81803337)
- National Natural Science Foundation of China (81803337)
- National Natural Science Foundation of China (81803337)
- National Natural Science Foundation of China (81872719)
- National Natural Science Foundation of China (81803337)
- Shandong Provincial Youth Innovation Team Development Plan of Colleges and Universities (2019-6-156, Lu-Jiao)
- Shandong Provincial Youth Innovation Team Development Plan of Colleges and Universities (2019-6-156, Lu-Jiao)
- Shandong Provincial Youth Innovation Team Development Plan of Colleges and Universities (2019-6-156, Lu-Jiao)
- Shandong Provincial Youth Innovation Team Development Plan of Colleges and Universities (2019-6-156, Lu-Jiao)
- Shandong Provincial Youth Innovation Team Development Plan of Colleges and Universities (2019-6-156, Lu-Jiao)
- Shandong Provincial Youth Innovation Team Development Plan of Colleges and Universities (2019-6-156, Lu-Jiao)
- Shandong Provincial Youth Innovation Team Development Plan of Colleges and Universities (2019-6-156, Lu-Jiao)
- Shandong Provincial Youth Innovation Team Development Plan of Colleges and Universities (2019-6-156, Lu-Jiao)
- Shandong Provincial Youth Innovation Team Development Plan of Colleges and Universities (2019-6-156, Lu-Jiao)
- Shandong Provincial Youth Innovation Team Development Plan of Colleges and Universities (2019-6-156, Lu-Jiao)
- Shandong Provincial Youth Innovation Team Development Plan of Colleges and Universities (2019-6-156, Lu-Jiao)
- Shandong Provincial Youth Innovation Team Development Plan of Colleges and Universities (2019-6-156, Lu-Jiao)
- Natural Science Foundation of Shandong Province (ZR2023MH313)
- Natural Science Foundation of Shandong Province (ZR2023MH313)
- Natural Science Foundation of Shandong Province (ZR2023MH313)
- Natural Science Foundation of Shandong Province (ZR2023MH313)
- Natural Science Foundation of Shandong Province (ZR2023MH313)
- Natural Science Foundation of Shandong Province (ZR2023MH313)
- Natural Science Foundation of Shandong Province (ZR2023MH313)
- Natural Science Foundation of Shandong Province (ZR2023MH313)
- Natural Science Foundation of Shandong Province (ZR2023MH313)
- Natural Science Foundation of Shandong Province (ZR2023MH313)
- Natural Science Foundation of Shandong Province (ZR2023MH313)
- Natural Science Foundation of Shandong Province (ZR2023MH313)
This publication has 40 references indexed in Scilit:
- Overview of Alzheimer's Disease Neuroimaging Initiative and future clinical trialsAlzheimer's & Dementia, 2024
- Assessing clinical progression measures in Alzheimer's disease trials: A systematic review and meta‐analysisAlzheimer's & Dementia, 2024
- Temporal trend and attributable risk factors of Alzheimer's disease and other dementias burden in China: Findings from the Global Burden of Disease Study 2021Alzheimer's & Dementia, 2024
- The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022Alzheimer's & Dementia, 2023
- The use of hippocampal grading as a biomarker for preclinical and prodromal Alzheimer's diseaseHuman Brain Mapping, 2023
- The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancerJournal of Cachexia, Sarcopenia and Muscle, 2022
- Using fractional polynomials and restricted cubic splines to model non‐proportional hazards or time‐varying covariate effects in the Cox regression modelStatistics in Medicine, 2021
- Sample size calculation for logrank test and prediction of number of events over timePharmaceutical Statistics, 2020
- APOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s PathogenesisMolecular Neurobiology, 2018
- Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal PersonsJAMA, 2017